Hanyu Pharmaceuticals and KuCoin have reached a strategic cooperation to explore innovative RWA projects
-
最新报道：According to People's Finance, Hanyu Pharmaceuticals and KuCoin have signed a letter of intent for a strategic partnership. The two parties intend to jointly explore and promote mainland China's first RWA tokenization pilot project in Hong Kong, using future revenue rights from innovative drug R&D as the underlying asset. According to the agreement, Hanyu Pharmaceuticals will leverage its technological expertise and R&D pipeline in the field of blockbuster GLP-1 peptide drugs as the underlying asset. KuCoin will leverage its expertise in blockchain technology, full-process RWA solutions, and global compliance resources to provide integrated support for the project, including on-chain mapping, asset tokenization, transaction matching, and profit distribution.
下一篇
UK fintech firm Revolut faces banking license approval block
- According to a report from Bijie.com, global fintech company Revolut, which has been waiti...
24小时热点
热点专题
407232